Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anidulafungin VS. Fluconazole in the Treatment of Patients With Candidemia and Other Forms of Invasive Candidiasis
NCT00058682Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Apr 2003
- Modality
- Small Molecules, Cyclic Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of anidulafungin in candidemia, invasive candidiasis, sponsored by National Cancer Institute. Started Apr 2003; status: completed.
02
Drugs
anidulafungin
03
Conditions
candidemiainvasive candidiasis
Beyond the preview
Go deeper on NCT00058682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00058682.